Non-interventional Study of Ocrelizumab in Participants With Relapsing or Primary Progressive Multiple Sclerosis

NCT ID: NCT03593590

Last Updated: 2025-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

1710 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-12

Study Completion Date

2026-01-23

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multicentre non-interventional study aimed at evaluating the real-world effectiveness and safety of ocrelizumab treatment in participants with relapsing multiple sclerosis (RMS) or primary progressive multiple sclerosis (PPMS), who have been prescribed ocrelizumab as per routine practice. This study will use a comprehensive combination of participant reported outcomes and conventional multiple sclerosis (MS) endpoints that measure clinical domains commonly affected by MS (e.g. fatigue, hand function, gait, cognition), and their impact on employment, activities of daily living, quality of life and healthcare resource utilization. The incidence, type, and pattern of serious adverse events (SAEs), and of adverse events (AEs) leading to treatment discontinuation will also be determined.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Multiple Sclerosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ocrelizumab

Participants with relapsing or primary progressive MS receiving ocrelizumab under routine clinical care.

Ocrelizumab

Intervention Type DRUG

Ocrelizumab is administered as an intravenous infusion in accordance with the approved labelling.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ocrelizumab

Ocrelizumab is administered as an intravenous infusion in accordance with the approved labelling.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ocrevus

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Must have a definite diagnosis of RMS or PPMS and in whom a decision to initiate ocrelizumab has been taken as part of routine clinical practice
* Must be prescribed ocrelizumab in line with the SmPC
* Must have provided signed informed consent
* Must be able and willing to complete the PROs as per clinical practice

Exclusion Criteria

* Previously treated with ocrelizumab (including phase II, phase III and phase IIIB clinical trials, local trials and investigator initiated study (IIS) as well as a pre-approval access or compassionate use programmes or local registries that are not compatible with the MuSicalE study design)
* Not receiving ocrelizumab in line with the SmPC
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hoffmann-La Roche

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Trials

Role: STUDY_DIRECTOR

Hoffmann-La Roche

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Landesklinikum Amstetten

Amstetten, , Austria

Site Status

Uniklinik fuer Neurologie, Medizinische Universitaet Innsbruck

Innsbruck, , Austria

Site Status

Kepler Universitätsklinikum GmbH - Neuromed Campus

Linz, , Austria

Site Status

Kepler Universitätskliniken GmbH - Med Campus III

Linz, , Austria

Site Status

Multiple Sklerose Zentrum

Melk, , Austria

Site Status

Klinik Floridsdorf

Vienna, , Austria

Site Status

Imeldaziekenhuis

Bonheiden, , Belgium

Site Status

AZ KLINA

Brasschaat, , Belgium

Site Status

Hospital Erasme

Brussels, , Belgium

Site Status

UZ Brussel

Brussels, , Belgium

Site Status

Cliniques Universitaires St-Luc

Brussels, , Belgium

Site Status

CHU de Charleroi

Charleroi, , Belgium

Site Status

UZ Antwerpen

Edegem, , Belgium

Site Status

CNRF - Centre Neurologique et Réadaptation Fonctionnelle

Fraiture, , Belgium

Site Status

Jessa Zkh (Campus Virga Jesse)

Hasselt, , Belgium

Site Status

AZ Groeninge

Kortrijk, , Belgium

Site Status

CHU Tivoli

La Louvière, , Belgium

Site Status

CHC MontLégia

Liège, , Belgium

Site Status

Nationaal MS Centrum

Melsbroek, , Belgium

Site Status

CHU UCL Mont-Godinne

Mont-godinne, , Belgium

Site Status

AZ Oostende

Ostend, , Belgium

Site Status

Revalidatie en MS Centrum

Overpelt, , Belgium

Site Status

AZ Delta (Campus Rumbeke)

Roeselare, , Belgium

Site Status

Clinica Amo - Assistencia Medica Em Oncologia

Salvador, Estado de Bahia, Brazil

Site Status

Hospital de Base do Distrito Federal

Brasília, Federal District, Brazil

Site Status

Instituto de Neurologia de Curitiba

Curitiba, Paraná, Brazil

Site Status

CPQuali Pesquisa Clinica Ltda

São Paulo, São Paulo, Brazil

Site Status

Hospital Universitario Gaffree e Guinle

Rio de Janeiro, , Brazil

Site Status

UMHAT 'Dr. Georgi Stranski', EAD

Pleven, , Bulgaria

Site Status

UMHAT Sveti Georgi Clinic of neurology

Plovdiv, , Bulgaria

Site Status

Shat Np Sveti Naum

Sofia, , Bulgaria

Site Status

First MHAT

Sofia, , Bulgaria

Site Status

Multiprofile Hosp. for Active Treatment

Sofia, , Bulgaria

Site Status

"City Clinic UMHAC" EOOD

Sofia, , Bulgaria

Site Status

Acibadem City Clinic Tokuda Hospital Ead

Sofia, , Bulgaria

Site Status

UMHAT "Sv. Ivan Rilski", EAD

Sofia, , Bulgaria

Site Status

UMHAT Alexandrovska, EAD

Sofia, , Bulgaria

Site Status

UMHAT Tsaritsa Yoanna - ISUL EAD

Sofia, , Bulgaria

Site Status

MBAL St. Marina

Varna, , Bulgaria

Site Status

Clinica Las Condes

Santiago, , Chile

Site Status

Fundacion ABOOD Shaio

Bogota, DC, , Colombia

Site Status

Centro Javeriano de Oncología

Bogotá, , Colombia

Site Status

Organizacion Sanitas Internacional

Bogotá, , Colombia

Site Status

Fundacion Clinica Valle del Lili

Cali, , Colombia

Site Status

Instituto Nacional del Cáncer Rosa Emilia Sánchez Pérez de Tavares (INCART)

Santo Domingo, , Dominican Republic

Site Status

Faculty of Medicine-Ain Shams University

Cairo, , Egypt

Site Status

Al Qahira Al Fatmiya Hospital

Cairo, , Egypt

Site Status

Clinical Research Center-Alex university

Cairo, , Egypt

Site Status

Ospedale San Salvatore

L’Aquila, Abruzzo, Italy

Site Status

Azienda Ospedaliero-Universitaria Consorziale Pol. di Bari

Bari, Apulia, Italy

Site Status

Ospedale F. Ferrari

Casarano, Apulia, Italy

Site Status

Università degli Studi della Campania Luigi Vanvitelli

Napoli, Campania, Italy

Site Status

AOU Seconda Università degli Studi

Napoli, Campania, Italy

Site Status

Arcispedale Sant'Anna

Cona, Emilia-Romagna, Italy

Site Status

A.O.U. di Parma

Parma, Emilia-Romagna, Italy

Site Status

Policlinico Tor Vergata Dip. Neuroscienze-Clinica Neurologica-UOSD Sclerosi Multipla

Rome, Lazio, Italy

Site Status

Azienda Ospedaliera Sant'Andrea

Rome, Lazio, Italy

Site Status

Irccs A.O.U.San Martino Ist

Genoa, Liguria, Italy

Site Status

Presidio Ospedaliero S.O.P.A. Micone

Sestri Ponente (GE), Liguria, Italy

Site Status

Ospedale S.Antonio Abate

Gallarate, Lombardy, Italy

Site Status

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Milan, Lombardy, Italy

Site Status

IRCCS Ospedale San Raffaele

Milan, Lombardy, Italy

Site Status

Fond. Istituto Neurologico C.Besta

Milan, Lombardy, Italy

Site Status

IRCCS Istituto Neurologico C. Mondino?Dip. Neurologia Neuroriabilitazione S.S. Sclerosi Multipla

Pavia, Lombardy, Italy

Site Status

Policlinico San Donato

San Donato Milanese, Lombardy, Italy

Site Status

IRCCS Istituto Neurologico Neuromed

Pozzilli, Molise, Italy

Site Status

Ospedale Regina Montis Regalis

Mondovì (CN), Piedmont, Italy

Site Status

Ospedale Binaghi

Cagliari, Sardinia, Italy

Site Status

AOU Policlinico V. Emanuele - P.O G. Rodolico

Catania, Sicily, Italy

Site Status

AOU Policlinico Giaccone

Palermo, Sicily, Italy

Site Status

Azienda Ospedaliero Universitaria Ospedali Riuniti Umberto I-G.M. Lancisi-G. Salesi Di Ancona

Torrette - Ancona, The Marches, Italy

Site Status

AOU Senese - Presidio Ospedaliero Le Scotte

Siena, Tuscany, Italy

Site Status

Ibn Sina Hospital

Kuwait City, , Kuwait

Site Status

Clinical Center of Montenegro

Podgorica, , Montenegro

Site Status

Amphia Ziekenhuis

Breda, , Netherlands

Site Status

St. Antonius Ziekenhuis Nieuwegein

Nieuwegein, , Netherlands

Site Status

Maasstadziekenhuis

NL -rotterdam, , Netherlands

Site Status

Ziekenhuis VieCuri Medisch Centrum

Venlo, , Netherlands

Site Status

Isala

Zwolle, , Netherlands

Site Status

Hospital Central del Instituto de Previsión Social

Asunción, , Paraguay

Site Status

Uniwersytecki Szpital Kliniczny w Bialymstoku

Bialystok, , Poland

Site Status

COPERNICUS Podmiot Leczniczy Sp. z o. o. Szpital im. M. Kopernika

Gdansk, , Poland

Site Status

Szpital Specjalistyczny im. Swi?tej Rodziny w Rudnej Ma?ej k. Rzeszowa

Głogów Małopolski, , Poland

Site Status

Gornoslaskie Centrum Medyczne

Katowice, , Poland

Site Status

UCK im. prof. K. Gibinskiego SUM

Katowice, , Poland

Site Status

SPZOZ Uniwersytecki Szp. Klin. nr1 im.N.Barlickiego UM

Lodz, , Poland

Site Status

SPZOZ Wojewodzki Szpital Specjalistyczny nr 3

Rybnik, , Poland

Site Status

Instytut Psychiatrii i Neurologii

Warsaw, , Poland

Site Status

Wojskowy Instytut Medyczny - Pa?Stwowy Instytut Badawczy

Warsaw, , Poland

Site Status

SPSK nr 1

Zabrze, , Poland

Site Status

Hospital Santo Antonio dos Capuchos

Lisbon, , Portugal

Site Status

Centro Hospitalar do Porto

Porto, , Portugal

Site Status

Hamad General Hospital

Doha, , Qatar

Site Status

Fundeni Clinical Institute

Bucharest, , Romania

Site Status

Spitalul Universitar de Urgenta Bucuresti

Bucharest, , Romania

Site Status

Spitalul Clinic Judetean de Urgenta Cluj-Napoca

Cluj-Napoca, , Romania

Site Status

Spitalul Clinic Judetean de Urgenta Sibiu

Sibiu, , Romania

Site Status

Spitalul Clinic Judetean de Urgenta Mures

Târgu Mureş, , Romania

Site Status

Jusupovskaya Hospital

Moscow, Moscow Oblast, Russia

Site Status

National Center of Social Significant Disease

Saint Petersburg, Sankt-Peterburg, Russia

Site Status

Regional clinical hospital named after prof. S.V. Ochapovsky

Krasnodar, , Russia

Site Status

State Novosibirsk Regional Clinical Hospital

Novosibirsk, , Russia

Site Status

King Abdul Aziz Medical City, King Fahd National Guard

Riyadh, , Saudi Arabia

Site Status

Clinical Center of Serbia

Belgrade, , Serbia

Site Status

Clinical Center Kragujevac

Kragujevac, , Serbia

Site Status

Clinical Center Nis

Niš, , Serbia

Site Status

Univerzitna Nemocnica - Nemocnica svateho Michala

Bratislava, , Slovakia

Site Status

Univerzitna nemocnica Bratislava - Nemocnica Ruzinov

Bratislava, , Slovakia

Site Status

Nemocnica akademika Ladislava Derera

Bratislava, , Slovakia

Site Status

Univerzitna nemocnica Martin

Martin, , Slovakia

Site Status

Ustredna vojenska nemocnica SNP Ruzomberok

Ružomberok, , Slovakia

Site Status

Fakultna nemocnica Trnava

Trnava, , Slovakia

Site Status

Hospital Universitario de Araba

Vitoria-Gasteiz, Alava, Spain

Site Status

Hospital General Universitario de Elche

Elche, Alicante, Spain

Site Status

Corporació Sanitaria Parc Taulí

Sabadell, Barcelona, Spain

Site Status

Hospital de Figueres

Figueres, Girona, Spain

Site Status

Hospital de Donostia

Donostia / San Sebastian, Guipuzcoa, Spain

Site Status

Complejo Hospitalario Universitario A Coruña (CHUAC)

A Coruña, LA Coruna, Spain

Site Status

Complejo Hospitalario Universitario de Santiago (CHUS) Servicio de Neurologia

Santiago de Compostela, LA Coruna, Spain

Site Status

Hospital General Universitario Santa Lucia

Cartagena (Murcia), Murcia, Spain

Site Status

Hospital Alvaro Cunqueiro

Vigo, Pontevedra, Spain

Site Status

Hospital Universitario de Canarias

San Cristóbal de La Laguna, Tenerife, Spain

Site Status

Hospital Nuestra Señora de Candelaria

Santa Cruz de Tenerife, Tenerife, Spain

Site Status

Hospital Nuestra Señora de Sonsoles

Ávila, , Spain

Site Status

Hospital de la Santa Creu i Sant Pau

Barcelona, , Spain

Site Status

Hospital Germans Trias i Pujol

Barcelona, , Spain

Site Status

Hospital Puerta del Mar

Cadiz, , Spain

Site Status

Hospital Universitario Reina Sofia

Córdoba, , Spain

Site Status

Hospital Regional Universitario de Malaga ? Hospital General

Málaga, , Spain

Site Status

Hospital Universitario Virgen de Arrixaca

Murcia, , Spain

Site Status

Hospital Universitario Virgen Macarena

Seville, , Spain

Site Status

Hospital Virgen del Rocío

Seville, , Spain

Site Status

Hospital Univ. Nuestra Señora de Valme

Seville, , Spain

Site Status

Hospital Clinico Universitario de Valencia

Valencia, , Spain

Site Status

Hospital General Universitario de Valencia

Valencia, , Spain

Site Status

Hospital Universitari i Politecnic La Fe

Valencia, , Spain

Site Status

Hacettepe University Medical Faculty

Ankara, , Turkey (Türkiye)

Site Status

Istanbul University Istanbul School of Medicine

Istanbul, , Turkey (Türkiye)

Site Status

Istanbul Universitesi - Cerrahpasa Cerrahpasa Tip Fakultesi

Istanbul, , Turkey (Türkiye)

Site Status

Ege University Medical Faculty

Izmir, , Turkey (Türkiye)

Site Status

Kocaeli University Hospital

Kocaeli, , Turkey (Türkiye)

Site Status

Mersin University Medical Faculty

Mersin, , Turkey (Türkiye)

Site Status

Ondokuz Mayis Univ. Med. Fac.

Samsun, , Turkey (Türkiye)

Site Status

Karadeniz Tecnical Uni. Med. Fac.

Trabzon, , Turkey (Türkiye)

Site Status

Mediclinic Parkview Hospital

Dubai-UAE, , United Arab Emirates

Site Status

Royal Victoria Hospital

Belfast, , United Kingdom

Site Status

University Hospital Coventry

Coventry, , United Kingdom

Site Status

Raigmore Hospital

Inverness, , United Kingdom

Site Status

Leeds General Infirmary

Leeds, , United Kingdom

Site Status

Lincoln County Hospital

Lincoln, , United Kingdom

Site Status

St George?s Hospital

London, , United Kingdom

Site Status

Luton General Hospital

Luton, , United Kingdom

Site Status

James Cook Hospital

Middlesbrough, , United Kingdom

Site Status

John Radcliffe Hospital

Oxford, , United Kingdom

Site Status

Derriford Hospital

Plymouth, , United Kingdom

Site Status

Royal Hallamshire Hospital

Sheffield, , United Kingdom

Site Status

Royal Stoke University Hospital

Stoke-on-Trent, , United Kingdom

Site Status

Sunderland Royal Hospital

Sunderland, , United Kingdom

Site Status

Morriston Hospital

Swansea, , United Kingdom

Site Status

Southmead Hospital

Westbury-on-Trym, Bristol, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Belgium Brazil Bulgaria Chile Colombia Dominican Republic Egypt Italy Kuwait Montenegro Netherlands Paraguay Poland Portugal Qatar Romania Russia Saudi Arabia Serbia Slovakia Spain Turkey (Türkiye) United Arab Emirates United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MN39889

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effects of Ocrevus in Relapsing Multiple Sclerosis
NCT04387734 ACTIVE_NOT_RECRUITING PHASE4